Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Abbott Imagines Future Of Health Care In 'Beyond Intervention' Report

Executive Summary

The company’s survey of more than 1,400 patients, physicians and administrators showed patients want more personalized care and physicians want more data.

You may also be interested in...



Abbott Launches NeuroSphere Virtual Clinic For Remote Neurostim Programming

The US FDA approved Abbott's system that allows physicians to communicate with patients and remotely program their neuromodulation device.

Expert Panel On Surgical Robotics Expects Autonomous Systems To Democratize Surgery

Autonomous robotic systems that enhance the skillset of surgeons face a gradual evolution, the experts agreed.

Study Suggests Big Health’s Sleep Therapy App May Also Reduce Depression Symptoms

A study comparing Big Health’s therapy app Sleepio to other interventions suggests that better sleep may help reduce depression.   

Related Content

Topics

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

MT142615

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel